# FDA Inspection 565068 - Celgene Corp., d.b.a. Abraxis BioScience LLC - February 26, 2009

Source: https://www.keypedia.com/records/fda_inspections/celgene-corp-dba-abraxis-bioscience-llc/4d35089a-8ea0-4a5b-b984-6b37bddb44b5
Source feed: FDA_Inspections

> FDA Inspection 565068 for Celgene Corp., d.b.a. Abraxis BioScience LLC on February 26, 2009. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 565068
- Company Name: Celgene Corp., d.b.a. Abraxis BioScience LLC
- Inspection Date: 2009-02-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 760361 - 2011-12-20](https://www.keypedia.com/records/fda_inspections/celgene-corp-dba-abraxis-bioscience-llc/c93a22f7-a85e-43e4-bce5-09d9cd7c7179)
- [FDA Inspection 644313 - 2010-02-08](https://www.keypedia.com/records/fda_inspections/celgene-corp-dba-abraxis-bioscience-llc/022a74f1-5cb8-42c6-95ae-7ea23605289b)

Company: https://www.keypedia.com/companies/celgene-corp-dba-abraxis-bioscience-llc/adaf2a93-2132-4073-a969-3ca7da90dff8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c